Innate Pharma SA
Chiara Vitale is currently an R&D Postdoctoral Scientist at Innate Pharma since February 2024, having progressed from roles as an R&D Associate and Visiting PhD Student. As a PhD student at the University of Genoa from November 2021 to April 2025, Chiara's research focuses on the myeloid and Natural Killer cell compartments in the bone marrow of Neuroblastoma samples, particularly in understanding tumor microenvironment interactions and exploring immunotherapeutic approaches. Prior experiences include a Research Fellow position at the National Research Council of Italy, where Chiara contributed to the FET-OPEN project aimed at optimizing a device for cancer research, and a waitstaff role at Mondo Pizza. Chiara holds a PhD in Clinical and Experimental Immunology and has completed both a Master's degree in Bioengineering and a Bachelor's degree in Biomedical Engineering, all from the University of Genoa.
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.